Article
Orphan Drug Status
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Shifting the Paradigm in Infant Atopic Dermatitis Treatment with Roflumilast
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Q&A: Peter Lio, MD, on Safety in Pediatric AD Management and the Promise of Precision Medicine
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Why Plant-Derived Exosomes are Revolutionizing Regenerative Skin Care, According to Frank Roesken, MD, PhD
Hydrafacial Launches HydraFillic 9-Peptide Booster for Advanced Skin Rejuvenation